Literature DB >> 20798197

Survival trends in head and neck cancer: opportunities for improving outcomes.

Cristina P Rodriguez, David J Adelstein.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20798197      PMCID： PMC3228045          DOI： 10.1634/theoncologist.2010-0237

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  13 in total

1.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

Authors: 
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

2.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Authors:  J Mork; A K Lie; E Glattre; G Hallmans; E Jellum; P Koskela; B Møller; E Pukkala; J T Schiller; L Youngman; M Lehtinen; J Dillner
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

3.  Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study.

Authors:  S R Schwartz; B Yueh; J K McDougall; J R Daling; S M Schwartz
Journal:  Otolaryngol Head Neck Surg       Date:  2001-07       Impact factor: 3.497

4.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

5.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

6.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

7.  The effect of smoking status on survival following radiation therapy for non-small cell lung cancer.

Authors:  Jana L Fox; Kenneth E Rosenzweig; Jamie S Ostroff
Journal:  Lung Cancer       Date:  2004-06       Impact factor: 5.705

8.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.

Authors:  Gregory M M Videtic; Larry W Stitt; A Rashid Dar; Walter I Kocha; Anna T Tomiak; Pauline T Truong; Mark D Vincent; Edward W Yu
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer.

Authors:  G P Browman; G Wong; I Hodson; J Sathya; R Russell; L McAlpine; P Skingley; M N Levine
Journal:  N Engl J Med       Date:  1993-01-21       Impact factor: 91.245
View more
  6 in total

1.  Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.

Authors:  Yichao Wang; Xiaolin Wang; Yu Zhang; Lan Yu; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 2.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

3.  CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Authors:  Aymee Perez; David M Neskey; Judy Wen; Lutecia Pereira; Erika P Reategui; W Jarrard Goodwin; Kermit L Carraway; Elizabeth J Franzmann
Journal:  Oral Oncol       Date:  2012-12-20       Impact factor: 5.337

4.  Epidemiological Characteristics and Survival Analysis of Patients With Nasopharyngeal Cancer in Western Greece.

Authors:  Christos S Avdulla; Theodoros Papadas; Nicholas Mastronikolis; Eleni Jelastopulu
Journal:  Cureus       Date:  2021-04-27

5.  PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.

Authors:  Wei-Chiao Chang; Shuo-Lun Wu; Wan-Chen Huang; Jinn-Yuan Hsu; Shih-Hung Chan; Ju-Ming Wang; Jhih-Peng Tsai; Ben-Kuen Chen
Journal:  Oncotarget       Date:  2015-04-10

6.  Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.

Authors:  Yu-Hsuan Huang; Che-Ying Chang; Yi-Zih Kuo; Wei-Yu Fang; Hung-Ying Kao; Sen-Tien Tsai; Li-Wha Wu
Journal:  Cancer Sci       Date:  2019-08-02       Impact factor: 6.716
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.